- United States
- /
- Electronic Equipment and Components
- /
- NasdaqGM:MASS
Some 908 Devices Inc. (NASDAQ:MASS) Shareholders Look For Exit As Shares Take 26% Pounding
908 Devices Inc. (NASDAQ:MASS) shareholders won't be pleased to see that the share price has had a very rough month, dropping 26% and undoing the prior period's positive performance. The good news is that in the last year, the stock has shone bright like a diamond, gaining 102%.
Although its price has dipped substantially, you could still be forgiven for thinking 908 Devices is a stock not worth researching with a price-to-sales ratios (or "P/S") of 3.3x, considering almost half the companies in the United States' Electronic industry have P/S ratios below 2.6x. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the elevated P/S.
View our latest analysis for 908 Devices
What Does 908 Devices' Recent Performance Look Like?
908 Devices certainly has been doing a good job lately as it's been growing revenue more than most other companies. It seems that many are expecting the strong revenue performance to persist, which has raised the P/S. However, if this isn't the case, investors might get caught out paying too much for the stock.
Keen to find out how analysts think 908 Devices' future stacks up against the industry? In that case, our free report is a great place to start.Do Revenue Forecasts Match The High P/S Ratio?
908 Devices' P/S ratio would be typical for a company that's expected to deliver solid growth, and importantly, perform better than the industry.
Retrospectively, the last year delivered an exceptional 36% gain to the company's top line. The latest three year period has also seen a 27% overall rise in revenue, aided extensively by its short-term performance. Accordingly, shareholders would have probably been satisfied with the medium-term rates of revenue growth.
Looking ahead now, revenue is anticipated to slump, contracting by 2.6% during the coming year according to the three analysts following the company. Meanwhile, the broader industry is forecast to expand by 15%, which paints a poor picture.
With this information, we find it concerning that 908 Devices is trading at a P/S higher than the industry. It seems most investors are hoping for a turnaround in the company's business prospects, but the analyst cohort is not so confident this will happen. There's a very good chance these shareholders are setting themselves up for future disappointment if the P/S falls to levels more in line with the negative growth outlook.
What Does 908 Devices' P/S Mean For Investors?
908 Devices' P/S remain high even after its stock plunged. We'd say the price-to-sales ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.
We've established that 908 Devices currently trades on a much higher than expected P/S for a company whose revenues are forecast to decline. Right now we aren't comfortable with the high P/S as the predicted future revenue decline likely to impact the positive sentiment that's propping up the P/S. Unless these conditions improve markedly, it'll be a challenging time for shareholders.
You should always think about risks. Case in point, we've spotted 1 warning sign for 908 Devices you should be aware of.
If companies with solid past earnings growth is up your alley, you may wish to see this free collection of other companies with strong earnings growth and low P/E ratios.
Valuation is complex, but we're here to simplify it.
Discover if 908 Devices might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGM:MASS
908 Devices
Provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications.
Flawless balance sheet with very low risk.
Similar Companies
Market Insights
Weekly Picks

This small cap is building the AI workforce of the future

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

Kraft Heinz (KHC): Less Drama, More Ketchup

Beyond 2026, Beyond a Double
Recently Updated Narratives
OCI is not being priced on asset value. That is the opportunity.
Kinepolis Group Set to Achieve 22.52% Revenue Growth Boost, Experts Dream
Salesforce Future Value Could Reach $263 as Market Remains Short-Sighted
Popular Narratives
QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

The $135 Billion Bet That Should Make Every Shareholder Nervous
